Improving access to appropriate post-exposure doxycycline for Lyme disease prophylaxis: role for community pharmacies

The Journal of Antimicrobial Chemotherapy
Allison M Dering-Anderson, Alex J Adams

Abstract

The transmission of Borrelia burgdorferi to humans through tick bites results in Lyme disease. Appropriate therapy for Lyme disease is antibacterial drugs, most often doxycycline. Patients often approach community pharmacists for self-care assistance with the symptoms of Lyme disease: fever, headache, fatigue and skin rash. Pharmacists with the patient history are trained and capable of appropriately dispensing doxycycline to treat these patients and prevent the spread of infection to the joints, nerves or heart. We challenge restrictions to the appropriate and timely provision of therapy for Lyme disease and encourage the use of community pharmacists in managing these patients.

References

Jul 14, 2001·The New England Journal of Medicine·R B NadelmanUNKNOWN Tick Bite Study Group
Oct 10, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary P WormserRobert B Nadelman
Apr 13, 2010·The Journal of Antimicrobial Chemotherapy·Stephen WarshafskyGary P Wormser
Jul 27, 2011·Journal of Public Health Management and Practice : JPHMP·Lisa A RosenfeldMitchel C Rothholz
Sep 1, 2012·Scandinavian Journal of Gastroenterology·Malte SchmidtKarl Søndenaa
Jan 11, 2014·Journal of the American Pharmacists Association : JAPhA·Anita N JacksonFrederic Silverblatt
Sep 23, 2014·Zoonoses and Public Health·A E PereaP S Mead
May 21, 2017·Journal of the American Pharmacists Association : JAPhA·Erica L DobsonUNKNOWN SIDP Community Pharmacy Antimicrobial Stewardship Task Force
May 4, 2018·MMWR. Morbidity and Mortality Weekly Report·Ronald RosenbergLyle R Petersen

❮ Previous
Next ❯

Citations

Aug 14, 2020·The Annals of Pharmacotherapy·Alex J Adams, Krystalyn K Weaver

❮ Previous
Next ❯

Related Concepts